- Home
- NOG vs FOLD Comparison
NOG vs FOLD Comparison
Compare NOG & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOG
- FOLD
- Stock Information
- Founded
- NOG 2006
- FOLD 2002
- Country
- NOG United States
- FOLD United States
- Employees
- NOG N/A
- FOLD N/A
- Industry
- NOG Oil & Gas Production
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- NOG Energy
- FOLD Health Care
- Exchange
- NOG Nasdaq
- FOLD Nasdaq
- Market Cap
- NOG 2.6B
- FOLD 2.5B
- IPO Year
- NOG N/A
- FOLD 2007
- Fundamental
- Price
- NOG $24.77
- FOLD $8.15
- Analyst Decision
- NOG Buy
- FOLD Strong Buy
- Analyst Count
- NOG 8
- FOLD 9
- Target Price
- NOG $31.14
- FOLD $26.44
- AVG Volume (30 Days)
- NOG 2.1M
- FOLD 5.8M
- Earning Date
- NOG 11-04-2025
- FOLD 11-05-2025
- Dividend Yield
- NOG 7.24%
- FOLD N/A
- EPS Growth
- NOG 6.84
- FOLD N/A
- EPS
- NOG 6.08
- FOLD N/A
- Revenue
- NOG $2,094,039,000.00
- FOLD $571,160,000.00
- Revenue This Year
- NOG $18.65
- FOLD $20.98
- Revenue Next Year
- NOG N/A
- FOLD $20.74
- P/E Ratio
- NOG $4.09
- FOLD N/A
- Revenue Growth
- NOG 6.25
- FOLD 25.35
- 52 Week Low
- NOG $19.88
- FOLD $5.51
- 52 Week High
- NOG $44.31
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- NOG 45.56
- FOLD 56.40
- Support Level
- NOG $24.04
- FOLD $7.69
- Resistance Level
- NOG $25.90
- FOLD $8.59
- Average True Range (ATR)
- NOG 0.95
- FOLD 0.37
- MACD
- NOG -0.11
- FOLD -0.05
- Stochastic Oscillator
- NOG 20.49
- FOLD 54.44
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.